deals

Inova Top 10 Newsletter – September 2017

It was a historical month in the field of immuno-oncology and the biopharma industry in general. Last month, we’ve seen back-to-back news about CAR-T therapy, from Gilead Science’s $ 11.9 Billion acquisition of Kite Pharma to the approval of the first CAR-T therapy in the world from Novartis. Meanwhile, we have seen several articles […]

By |September 12th, 2017|Uncategorized|0 Comments

Winning at Dealmaking – Shots on Goal vs. Taking the Right Shot

By |July 13th, 2010|Uncategorized|Comments Off on Winning at Dealmaking – Shots on Goal vs. Taking the Right Shot